Back to Search
Start Over
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
- Source :
-
Transplantation proceedings [Transplant Proc] 1997 Feb-Mar; Vol. 29 (1-2), pp. 1549. - Publication Year :
- 1997
- Subjects :
- Costs and Cost Analysis
Graft Rejection economics
Humans
Illinois
Immunosuppressive Agents therapeutic use
Length of Stay economics
Muromonab-CD3 therapeutic use
Tacrolimus therapeutic use
Graft Rejection therapy
Immunosuppressive Agents economics
Muromonab-CD3 economics
Tacrolimus economics
Subjects
Details
- Language :
- English
- ISSN :
- 0041-1345
- Volume :
- 29
- Issue :
- 1-2
- Database :
- MEDLINE
- Journal :
- Transplantation proceedings
- Publication Type :
- Academic Journal
- Accession number :
- 9123421
- Full Text :
- https://doi.org/10.1016/s0041-1345(96)00671-9